Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on German Health Review.
Press releases published on July 29, 2025
Empo Health Selects Interlynk to Enhance Cybersecurity & FDA Compliance for Remote Diabetic Foot Ulcer Monitoring
EIN Presswire
·
July 29, 2025
Partnership accelerates FDA-aligned cybersecurity compliance for Empo Health’s remote diabetic care platform through automated SBOM and vulnerability management MENLO PARK, CA, UNITED STATES, July 29, 2025 /EINPresswire.com/ -- Interlynk, a leading …
TD2 Oncology and Curadh Enter Strategic Collaboration to Advance Radiopharmaceutical Clinical Trials
EIN Presswire
·
July 29, 2025
Partnership brings together deep clinical expertise and novel radiopharmaceutical innovation to accelerate treatments for patients with aggressive solid tumors SCOTTSDALE, AZ, UNITED STATES, July 29, 2025 /EINPresswire.com/ -- TD2 Oncology (TD2), a …
DoktorABC startet Petition gegen geplante Einschränkungen bei medizinischem Cannabis
EIN Presswire
·
July 29, 2025
Petition von DoktorABC fordert Erhalt von Telemedizin und Apothekenversand für medizinisches Cannabis BERLIN, GERMANY, July 29, 2025 /EINPresswire.com/ -- „Ich fordere Bundesgesundheitsministerin Nina Warken auf, die unzähligen Kommentare der mehr als …
Enovation in IOL Material: VSY Biotechnology’s Enova® Premium IOLs Set New Standard with 100% Glistening Free Technology
EIN Presswire
·
July 29, 2025
LEINFELDEN-ECHTERDINGEN, GERMANY, July 29, 2025 /EINPresswire.com/ -- VSY Biotechnology GmbH’s groundbreaking Enova® intraocular lens is reshaping expectations in the ophthalmic industry. As the first and only 100% glistening-free hydrophobic acrylic IOL …
CorTec Announces Neurotech Milestone: First Human Implantation of a Brain-Computer Interface made in Germany
GlobeNewswire
·
July 29, 2025
FREIBURG, Germany, July 29, 2025 (GLOBE NEWSWIRE) -- CorTec GmbH, a pioneer in active implantable medical technologies, today announced the first human implantation of its proprietary BCI system, Brain Interchange™, marking a pivotal advance in translating …
MetrioPharm’s MP1032 Receives EMA Orphan Drug Designation in Duchenne Muscular Dystrophy
GlobeNewswire
·
July 29, 2025
European Medicines Agency recognizes potential of lead compound MP1032 in addressing a high unmet medical need in Duchenne Muscular Dystrophy (DMD) Designation is paving the way for safer long-term therapy MP1032 has demonstrated ability to preserve muscle …